Sezary Syndrome is a rare and aggressive form of cutaneous T-cell lymphoma (CTCL), characterized by the presence of malignant T-cells in the skin, lymph nodes, and blood. With rising awareness, advancements in targeted therapies, and increasing incidence of rare hematological cancers, the Sezary Syndrome Treatment Market is emerging as a crucial segment in the global oncology...